Overview
Comparison Between Levosimendan and Adrenaline in CABG Patients
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-05-01
2024-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to compare between levosimendan and adrenaline in patients with pre-existing impaired systolic function (EF 30-40%), undergoing elective on-pump CABG, as regards hemodynamics and echocardiographic parameters.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Assiut UniversityTreatments:
Epinephrine
Epinephryl borate
Racepinephrine
Simendan
Criteria
Inclusion Criteria:- ischemic hear disease
- age 18 and 60 years
- low left ventricular function (ejection fraction 30 - 40%),
- elective coronary artery bypass grafting (CABG) surgery
Exclusion Criteria:
- Age over 60 years
- Patients with end organ failure (renal, liver)
- Associated significant valve lesions
- Uncontrolled diabetes mellitus
- Emergency surgery